sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1310.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 5-Dec-2016
IASLC 2016 World Conference on Lung Cancer
Global public health advocates open new fronts in war on tobacco
Efforts to control tobacco as a public health threat have escalated as clinicians and public health advocates have coalesced to beat back threats from tobacco companies through public advocacy, public health, and pension reform. Today, public health advocates from Brazil, Malaysia, Ireland, Australia, and Uruguay presented different strategies that have effectively reigned in the global threat of tobacco companies at a press briefing held at IASLC 17th World Conference on Lung Cancer (WCLC).

Contact: Chris Martin
cmartin@davidjamesgroup.com
630-670-2745
International Association for the Study of Lung Cancer

Public Release: 2-Dec-2016
The American Journal of Clinical Nutrition
Saturated fat could be good for you
A Norwegian study shows that saturated fat actually could be good for you. The quality of the food, whether it's highly processed or not, could have a larger impact on your health.

Contact: Simon E. Nitter Dankel
simon.dankel@uib.no
47-943-08637
The University of Bergen

Public Release: 1-Dec-2016
Monell Center receives grant to develop technologies to improve taste of lifesaving drugs
The Monell Center announced today that it has received a $345,000 grant from the Bill & Melinda Gates Foundation. The grant supports an innovative global health research project titled, 'Developing Novel Pediatric Formulation Technologies for Global Health: Human Taste Assays.'
Bill & Melinda Gates Foundation

Contact: Leslie Stein
stein@monell.org
267-519-4707
Monell Chemical Senses Center

Public Release: 1-Dec-2016
PLOS Neglected Tropical Diseases
Test created in Brazil can diagnose 416 viruses from tropical regions
Researchers from the University of São Paulo (USP) in Brazil have developed a platform that analyzes clinical samples from patients to diagnose infection by 416 viruses found in the world's tropical regions. The tool can be used to assist epidemiological surveillance by detecting pathogens with the potential to cause epidemics in humans.
São Paulo Research Foundation

Contact: Samuel Antenor
samuel@fapesp.br
55-113-838-4381
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 1-Dec-2016
Findings show significant progress against HIV epidemic in Africa; 90-90-90 goals in reach
National surveys in Zimbabwe, Malawi, and Zambia reveal exceptional progress against HIV, with decreasing rates of new infection, stable numbers of people living with HIV, and more than half of all those living with HIV showing viral suppression through use of antiretroviral medication. For those on antiretroviral medication, viral suppression is close to 90 percent. Thirty-five years into the global HIV epidemic, these findings are a clear sign of progress and source of hope for the rest of the world.
US President's Emergency Plan for AIDS Relief, US Centers for Disease Control and Prevention

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 1-Dec-2016
New England Journal of Medicine
IPM's ring study results published in New England Journal of Medicine
IPM announced today that the New England Journal of Medicine has published results from the Ring Study, a Phase III clinical trial of IPM's vaginal ring to prevent HIV. Also see NEJM's short video summary. The study's key findings, announced earlier this year, show that a vaginal ring that slowly releases the antiretroviral drug (ARV) dapivirine over the course of one month safely helps reduce the risk of HIV infection in women.

Contact: Holly Seltzer
hseltzer@IPMglobal.org
301-608-4277
International Partnership for Microbicides (IPM)

Public Release: 1-Dec-2016
Cell Stem Cell
How Zika infects the growing brain
Studies have suggested that Zika enters neural progenitor cells by grabbing onto a specific protein called AXL on the cell surface. Now, scientists at the Harvard Stem Cell Institute and Novartis have shown that this is not the only route of infection. The scientists demonstrated that Zika infected neural progenitor cells even when the cells did not produce the AXL surface protein that is widely thought to be the main vehicle of entry for the virus.
The Stanley Center for Psychiatric Research, Harvard Stem Cell Institute

Contact: David Cameron
david_cameron@harvard.edu
617-495-2931
Harvard University

Public Release: 1-Dec-2016
PLOS Neglected Tropical Diseases
Unique strains of Brazilian leishmaniasis set apart by genetics
Some of the roughly 1 million cases a year of the parasitic disease leishmaniasis don't fit with the standard definition of the disease -- the patients have unusual symptoms and front-line medicines don't work. Now, researchers have discovered why many of these cases are so different -- they're caused by parasites with distinct genetic variations. The finding, reported in PLOS Neglected Tropical Diseases, was made by studying patients in northeast Brazil but may hold true elsewhere around the world.

Contact: PLOS Neglected Tropical Diseases
plosntds@plos.org
PLOS

Public Release: 30-Nov-2016
PLOS ONE
Benefits of daily aspirin outweigh risk to stomach
Stomach bleeds caused by aspirin are considerably less serious than the spontaneous bleeds that can occur in people not taking the drug, concludes a study led by Cardiff University.

Contact: Julia Short
ShortJ4@cardiff.ac.uk
44-029-208-75596
Cardiff University

Public Release: 30-Nov-2016
Ophthalmology
Zika and glaucoma linked for first time in new study
A team of researchers in Brazil and at the Yale School of Public Health has published the first report demonstrating that the Zika virus can cause glaucoma in infants who were exposed to the virus during gestation.

Contact: Michael Greenwood
michael.greenwood@yale.edu
203-737-5151
Yale University

Public Release: 30-Nov-2016
PLOS Medicine
Vital vaccine could 'reduce burden' of dengue disease in hardest-hit regions
A team of international researchers, including Dr. Mario Recker from the University of Exeter, have looked at the impact and cost-effectiveness of the vaccine, called Dengvaxia, under a host of varying conditions.
World Health Organization, Gavi, The Vaccine Alliance, University of Western Australia, Royal Society University Research Fellowship, UK Medical Research Council, National Institute for Health Research, NIH/National Institute of General Medical Sciences

Contact: Duncan Sandes
D.Sandes@exeter.ac.uk
01-392-722-391
University of Exeter

Public Release: 30-Nov-2016
2016 Royal Australian Chemical Institute Organic One Day Symposium
Breaking good: School students make costly drug cheaply using open source approach
High school students under University of Sydney guidance have shown how simple it is to make a version of the life-saving medicine Daraprim, whose price was the subject of controversy last year when it jumped more than 5,000 percent.

Contact: Vivienne Reiner
vivienne.reiner@sydney.edu.au
61-293-512-390
University of Sydney

Public Release: 30-Nov-2016
Lancet Infectious Diseases
HIV patients showing signs of multidrug resistance in Africa
Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL (University College London) and funded by Wellcome. The research, co-authored by researchers at the London School of Hygiene and Tropical Medicine and published in The Lancet Infectious Diseases, studied 712 HIV patients across the world whose HIV was not controlled by antiretrovirals.
Wellcome

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-203-108-3844
University College London

Public Release: 30-Nov-2016
Nature Communications
A method for storing vaccines at room temperature
Several simple and inexpensive techniques make it possible to store antiviral-vaccines at room temperature for several months. This discovery by EPFL researchers and partners could make a difference in inaccessible areas and developing countries where maintaining cold-chain transportation of vaccines is complicated and expensive.

Contact: Francesco Stellacci
francesco.stellacci@epfl.ch
41-216-937-872
Ecole Polytechnique Fédérale de Lausanne

Public Release: 29-Nov-2016
PLOS Medicine
Dengue vaccine estimated to reduce disease burden in dengue-affected areas
The first available dengue vaccine, CYD-TDV (Dengvaxia), is estimated to reduce the burden of dengue and be potentially cost effective in settings where infections with dengue are common, according to a study published by Stefan Flasche from the London School of Hygiene & Tropical Medicine, UK and an international consortium of dengue experts, in PLOS Medicine.

Contact: Stefan Flasche
Stefan.Flasche@lshtm.ac.uk
PLOS

Public Release: 25-Nov-2016
London School of Hygiene & Tropical Medicine named University of the Year 2016
The London School of Hygiene & Tropical Medicine has been awarded the prestigious University of the Year award at the Times Higher Education Awards 2016. The School was the judges' unanimous choice for the award, given in recognition of its response to the Ebola epidemic in West Africa in 2014-15.

Contact: Jenny Orton
press@lshtm.ac.uk
207-927-2802
London School of Hygiene & Tropical Medicine

Public Release: 23-Nov-2016
PLOS Computational Biology
Malaria elimination in Sub-Saharan Africa predicted to be possible under right conditions
Malaria elimination in historically high transmission areas like southern Africa is possible with tools that are already available, provided those tools are deployed aggressively -- according to new research published in PLOS Computational Biology.

Contact: Jaline Gerardin
jgerardin@intven.com
PLOS

Public Release: 22-Nov-2016
PLOS Medicine
Giving older children preventive malaria drugs reduces cases and transmission
Giving preventive antimalarial drugs to children up to age 10 during the high malaria season in Senegal more than halved cases of malaria in that age group, according to new research published in PLOS Medicine.
Bill & Melinda Gates Foundation

Contact: James Barr
press@lshtm.ac.uk
020-792-72082
London School of Hygiene & Tropical Medicine

Public Release: 22-Nov-2016
PLOS Medicine
Seasonal malaria chemoprevention in Senegalese children lowers overall malaria burden
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.

Contact: Paul John Milligan
paul.milligan@lshtm.ac.uk
PLOS

Public Release: 22-Nov-2016
PLOS Medicine
Minimally invasive autopsies in lower-income countries: Reliability, acceptability
High concordance rates were observed between diagnoses obtained using a simplified minimally invasive autopsy method and those determined from complete autopsies in a series of deceased adult patients in Mozambique, according to research published in PLOS Medicine by Jaume Ordi and colleagues. In a linked research article, Khátia Munguambe and colleagues observed that the hypothetical acceptability of the minimally invasive autopsy and willingness to know the cause of death were high across five settings in Gabon, Kenya, Mali, Mozambique, and Pakistan.

Contact: Jaume Ordi
jordi@clinic.ub.es
PLOS

Public Release: 21-Nov-2016
Nature Microbiology
NIAID-supported scientists sequence, explore the genome of the river blindness parasite
Scientists have sequenced the genome of the parasitic worm responsible for causing onchocerciasis -- an eye and skin infection more commonly known as river blindness. Through their work, researchers have gained insight into the workings of the parasite and identified proteins that potentially could be targeted with existing drugs or provide areas for developing new treatments and a preventive vaccine. The NIAID-supported research is described in a pair of papers published this week in Nature Microbiology.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Elizabeth Deatrick
elizabeth.deatrick@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-Nov-2016
International Journal of Environmental Research and Public Health
El Niño conditions in the Pacific precedes dengue fever epidemics in South Asia
Researchers have found a strong association between El Niño-Southern Oscillation conditions in the Pacific to observed weather and dengue epidemics in Sri Lanka. According to a study published in the International Journal of Environmental Research and Public Health, el Niño activity -- measured in sea surface temperature in the pacific -- impacts rainfall and temperatures in Sri Lanka and thus contributes to exacerbated dengue epidemics six months later.
DengueTools FP7, Umeå University, Ministry of Health in Sri Lanka

Contact: Daniel Harju
daniel.harju@umu.se
46-725-522-918
Umea University

Public Release: 21-Nov-2016
Annals of Internal Medicine
Effect of collaborative care with occupational therapy indeterminate for slowing functional decline from dementia
Two years of in-home occupational therapy combined with collaborative care did not slow the rate of functional decline among persons with Alzheimer disease. Given that family members often shoulder the burden of caring for patients with dementia, the authors suggest that research is needed to identify strategies to support caregivers in the home. The findings are published in Annals of Internal Medicine.

Contact: Angela Collom
acollom@acponline.org
215-351-2653
American College of Physicians

Public Release: 18-Nov-2016
Journal of the American Society of Nephrology
APOL1 linked to reduced nephrocyte function, increased cell size, accelerated cell death
A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published Nov. 18 in the Journal of the American Society of Nephrology.

Contact: Dee Henderson
dhenderso2@childrensnational.org
443-610-9826
Children's National Health System

Public Release: 18-Nov-2016
EBioMedicine
UTMB researchers create powerful new tools to combat Zika
New research from the University of Texas Medical Branch in Galveston, in collaboration with Southwest University in Chongqing, China and the University of Leuven in Belgium, have developed a way to replicate the basic structure of the Zika virus, stripping it of the genes that make the virus infectious. The replicon system research was spearheaded by Dr. Xuping Xie and recently published in EBioMedicine.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Showing releases 1-25 out of 1310.

1 | 2 | 3 | 4 | 5 > >>